2012
DOI: 10.1097/pcc.0b013e3182455558
|View full text |Cite
|
Sign up to set email alerts
|

Exposure to di(2-ethylhexyl) phthalate in premature neonates in a neonatal intensive care unit in Taiwan

Abstract: These data suggest that polyvinyl chloride-containing devices are the major defining factor in di(2-ethylhexyl) phthalate exposure levels in neonates in the neonatal intensive care unit. We urge the use of polyvinyl chloride-free or alternative materials in medical devices, especially for endotracheal tubes, orogastric tubes, nasogastric tubes, and intravenous tubing in the neonatal intensive care unit. The health effects of high di(2-ethylhexyl) phthalate exposure on premature neonates in the neonatal intensi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(23 citation statements)
references
References 34 publications
0
23
0
Order By: Relevance
“…It has previously been shown that premature children are highly exposed to DEHP from medical equipment (Silva et al 2006; Su et al 2012; Weuve et al 2006). It was assumed that this exposure was restricted to DEHP (Weuve et al 2006).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…It has previously been shown that premature children are highly exposed to DEHP from medical equipment (Silva et al 2006; Su et al 2012; Weuve et al 2006). It was assumed that this exposure was restricted to DEHP (Weuve et al 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Current risk assessments do not account for this. Because the carboxylated metabolite of DEHP has only recently become available, previous studies on DEHP exposure of newborns may have systematically underestimated exposure levels (Su et al 2012; Weuve et al 2006). …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Typical daily phthalate intake in humans is estimated at 1.7-52.1 μg/kg/day (Doull et al, 1999;Koch et al, 2003;McKee et al, 2004;Frederiksen et al, 2011;Martinez-Arguelles et al, 2013), whereas children exposure is 2-to 4-fold higher than adults (Koch et al, 2005;Moody et al, 2013). Moreover, individuals, especially children with long-term medical conditions have much greater exposure than general population since the use of phthalates in medications and medical devices (Moody et al, 2013), with an estimated exposure of 20 mg phthalate per day (Plonait et al, 1993;Green et al, 2005;Su et al, 2012;Moody et al, 2013). Phthalates are considered to be one of the major groups of antiandrogenic substances (Grady and Sathyanarayana, 2012;Knez, 2013).…”
Section: Phthalatesmentioning
confidence: 97%
“…17 Infants maintained on parenteral nutrition exhibit variable increases in serum concentrations of DEHP at the end of the treatment period. 18 Given these findings, use of polyvinyl chloride-free medical devices is recommended in neonatal intensive care units.…”
Section: Phthalatesmentioning
confidence: 99%